+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type, Product, Technology, Application, and End User, and Country

  • ID: 5295153
  • Report
  • February 2021
  • Region: North America
  • 158 Pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2022

FEATURED COMPANIES

  • Company Profiles
  • MEDIPOST
  • Mesoblast Limited
  • NuVasive, Inc
  • Smith & Nephew
  • Vericel Corporation
According to a new market research study of “North America Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Analysis - by Therapy Type, Product, Technology, Application, and End User,” the North America cell therapy market is projected to reach US$ 5,740.14 million by 2027 from US$ 3,262.56 million in 2019. The market is estimated to grow at CAGR of 7.4% from 2020 to 2027. The report highlights trends prevailing in the North America cell therapy market and the factors driving market along with those that act as hindrances.

Based on therapy type, the North America cell therapy market is segmented into allogeneic, and autologous. The allogeneic segment held the largest share of the market in 2019. The growth of segment is expected due to increasing focus on the development of regenerative therapies by increasingly emphasizing innovations and manufacturing. In addition, the availability of substantial number of approved products for clinical use is likely to continue the growth of segment during the forecast period. However, the autologous segment is anticipated to register the highest CAGR in the market during the forecast period.

The North America cell therapy market is expected to grow owing to factors such as growing collaborative efforts to promote cell therapy, and developments in cell therapy against COVID-19. However, stringent regulations is likely to restraint the market growth during the forecast period.

Vericel Corporation; MEDIPOST; NuVasive, Inc; Mesoblast Limited; Smith & Nephew; Bristol-Myers Squibb Company; Stemedica Cell Technologies, Inc, and Castle Creek Biosciences, Inc. are among the leading companies operating in the North America cell therapy market.

The report segments North America cell therapy market as follows:

By Therapy Type
  • Allogeneic
  • Autologous
By Product
  • Consumables
  • Equipment
  • Systems and Software
By Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology
By Application
  • Oncology
  • Cardiovascular
  • Orthopedic
  • Wound Management
  • Other Applications
By End User
  • Research Institutes
  • Hospitals
  • Others
By Country
  • US
  • Canada
  • Mexico
Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America airport runway FOD detection systems market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America airport runway FOD detection systems market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging market.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the airport runway FOD detection systems market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Company Profiles
  • MEDIPOST
  • Mesoblast Limited
  • NuVasive, Inc
  • Smith & Nephew
  • Vericel Corporation
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North American Cell Therapy Market- By Therapy Type
1.3.2 North American Cell Therapy Market- By Product
1.3.3 North American Cell Therapy Market - By Technology
1.3.4 North American Cell Therapy Market - By Application
1.3.5 North American Cell Therapy Market - By End User
1.3.6 North American Cell Therapy Market- By Region

2. Cell Therapy Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cell Therapy - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Expert Opinion

5. North America Cell Therapy Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Collaborative Efforts to Promote Cell Therapy
5.1.2 Developments in Cell Therapy Against COVID-19
5.2 Key Market Restraints
5.2.1 Stringent Regulations
5.3 Key Market Opportunities
5.3.1 Focus on Cell Therapy to Treat Diabetes
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis

6. Cell Therapy Market - Regional Analysis
6.1 North America Cell Therapy Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players

7. Cell Therapy Market Analysis - By Therapy Type
7.1 Overview
7.2 Cell Therapy Market Revenue Share, by Therapy Type, 2019 and 2027 (%)
7.2.1 North America Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Cell Therapy Market - By Product
8.1 Overview
8.2 Cell Therapy Market, by Product, 2019 and 2027 (%)
8.2.1 North America Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Cell Therapy Market - By Technology
9.1 Overview
9.2 Cell Therapy Market, by Technology, 2019 and 2027 (%)
9.2.1 North America Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Cell Therapy Market - By Application
10.1 Overview
10.2 Cell Therapy Market, by Application, 2019 and 2027 (%)
10.2.1 North America Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Cell Therapy Market - By End User
11.1 Overview
11.2 Cell Therapy Market, by End User, 2019 and 2027 (%)
11.2.1 North America Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

12. Cell Therapy Market- Regional Analysis
12.1 North America: Cell Therapy Market
12.1.1 Overview
12.1.2 North America: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 North America: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.4 North America: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.5 North America: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.6 North America: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.7 North America: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.8 North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.1.9 US: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 US: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.2 US: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.3 US: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.9.4 US: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.9.5 US: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.9.6 US: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.10 Canada: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Canada: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Canada: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Canada: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.10.4 Canada: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Canada: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Canada: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.11 Mexico: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.1 Mexico: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.11.3 Mexico: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.11.4 Mexico: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.11.5 Mexico: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.11.6 Mexico: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)

13. Impact of COVID-19 Pandemic on North America Cell Therapy Market
13.1 North America: Impact Assessment of COVID-19 Pandemic

14. Cell therapy Market-Key Company Profiles
14.1 Vericel Corporation
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MEDIPOST
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 NuVasive, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mesoblast Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Smith & Nephew
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Stemedica Cell Technologies, Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Castle Creek Biosciences, Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms

List of Tables
Table 1. North America Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. North America Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. North America: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 7. North America: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 8. North America: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 9. North America: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. North America: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 11. US: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 12. US: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 13. US: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 14. US: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. US: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Canada: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 17. Canada: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. Canada: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 19. Canada: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Canada: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. Mexico: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Glossary of Terms, Cell Therapy Market

List of Figures
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market Segmentation - By Region
Figure 3. North America Cell Therapy Market Overview
Figure 4. Allogeneic Segment Held Largest Share Of Therapy Type Segment In The Cell Therapy Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Cell Therapy Market - Revenue Forecast And Analysis - 2019- 2027
Figure 8. Market Positioning Of Key Players In Cell Therapy Market
Figure 9. Cell Therapy Market Revenue Share, by Therapy Type, 2019 and 2027 (%)
Figure 10. Allogeneic: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Autologous: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Cell Therapy Market, by Product 2019 and 2027 (%)
Figure 13. Consumables: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Equipment: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Systems and Software: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Cell Therapy Market, by Technology, 2019 and 2027 (%)
Figure 17. Viral Vector Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Genome Editing Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Somatic Cell Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cell Immortalization Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Plasticity Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Three-Dimensional Technology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Cell Therapy Market, by Application, 2019 and 2027 (%)
Figure 24. Oncology: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Cardiovascular: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Orthopedic: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Wound Management: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other Applications: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cell Therapy Market, by End User, 2019 and 2027 (%)
Figure 30. Hospitals Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Research Institutes: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Others: Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Cell Therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 34. North America: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
Figure 36. US: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in North American Country Markets
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Company Profiles
  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc
  • Mesoblast Limited
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll